Vial set · Wolverine
BPC-157 + TB-500
A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research.
Product information
A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research. Studies consider cell migration, inflammatory signalling and wound-repair pathways, but the combined ‘Wolverine’ format is not an approved clinical formulation.
Evidence and sources at a glance
- Human evidence
- Robust, replicated controlled human evidence for BPC-157 is absent, and the marketed blend itself lacks an established clinical evidence base.
- Regulatory context
- The combined product is not an approved UK medicine and should not be described as a proven injury treatment.
- BPC-157 systematic review ↗Peer-reviewed overview of evidence and translational limitations.
- PubMed thymosin beta-4 literature ↗Indexed research on thymosin beta-4 biology; not proof of a particular TB-500 product.
